India's CDSCO Grants Regulatory Approval for Takeda’s Qdenga Dengue Vaccine

CMS Outlines Operational Path for 2028 Maximum Fair Price Compliance

CMS Targets Fee-for-Service Fragmentation in New 2027 Policy Roadmap

Alzheimer’s Association International Conference (AAIC) 2026 | iPharmaCenter

Top 10 U.S. healthcare companies by 2026 revenue | iPharmaCenter

FDA Approves First Oral PCSK9 Inhibitor, Signaling Shift in Dyslipidemia Treatment

American Academy of Dermatology (AAD) Innovation Academy 2026

Eli Lilly to Acquire AtaiBeckley for Up to $3.8 Billion, Expanding Psychedelic Neuroscience Pipeline

European Commission Grants Approval for Oral Semaglutide in Weight Management

Aetna Survey Highlights Evolving Payer-Provider Confidence Landscape | iPharmaCenter

Top 10 pharmaceutical companies by revenues in 2026 | Official Figures | iPharmaCenter

FDA Grants Landmark Approval for REVTORPYK: A New Standard for PIK3CA Wild-Type Breast Cancer

CMS Proposes Major Medicare Overhaul: Shifting Toward Accountable Care and Value-Based Payments

Germany Enacts 2026 Healthcare Reform to Curb Statutory Insurance Spending

AstraZeneca Bolsters Oncology Pipeline with Global Acquisition of Zegfrovy

FDA Approval of Sarclisa Escena Marks Shift Toward Subcutaneous Oncology Delivery | iPharmaCenter

Navigating the Shift: Employer-Led Demands Reshape Pharmacy Benefit Management

FDA Approves KEYTRUDA-Padcev Combo as First Perioperative Standard for Muscle-Invasive Bladder Cancer

CMS 2027 Overhaul: Restructuring the Economics of Outpatient Care

Vertex moves to buy Crinetics in $10 billion endocrinology deal | iPharmaCenter

Orpathys wins conditional NMPA approval for MET‑amplified gastric cancer in China | iPharmaCenter

Optum Financial Adds Alegeus Platform To Deepen Consumer Health Benefits And Payments | iPharmaCenter

Myricx Bio Deal Brings Novel N‑Myristoyltransferase Inhibitor ADCs Into Novartis Portfolio | iPharmaCenter

Enhertu Gains EU Tumour‑Agnostic Approval For HER2‑Positive Metastatic Solid Tumours | iPharmaCenter

European Academy of Neurology (EAN) Congress 2026 | iPharmaCenter

ESMO Gastrointestinal Cancers Congress 2026 | iPharmaCenter

NICE Opens Access to New Immunotherapy in Cervical Cancer and First Disease‑Modifying Drug in Early Type 1 Diabetes

Hospital and Drug Costs Outpace Contributions in Germany, Raising Pressure on Pharma Pricing

CVS Pharmacy Joins Medicare GLP-1 Bridge and Scales Weight‑Loss Access Across the U.S. | iPharmaCenter

June 2026: CHMP Signals New Options in CLL, TNBC and Multiple Myeloma

Medicare GLP‑1 Bridge Program: Eligibility, Costs, and Drug Details | iPharmaCenter

Merck Advances Pipeline with Tulisokibart Phase 3 Data and EU Nod for Keytruda-Padcev | iPharmaCenter

CDSCO Approves AstraZeneca's Enhertu as New First-Line Combination for HER2-Positive Breast Cancer in India

Sanofi’s Cenrifki Wins EU Approval for Non-Relapsing Secondary Progressive MS | iPharmaCenter

Japan Approves Sanofi’s Wayrilz for Chronic Immune Thrombocytopenia Treatment | iPharmaCenter

AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Immunology Deal | iPharmaCenter